• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Anthem More Than Doubled the Members Receiving Whole-Person Treatment for Opioid Use Disorder

Article

Innovative providers, collaborations and payment strategies credited for increase.

Indianapolis—Anthem Blue Cross and Blue Shield more than the doubled the number of members in Medicaid, individual and employer-sponsored plans receiving whole-person therapies believed to produce better outcomes for opioid use disorder.

To make a positive impact on member health and lessen the impact of the opioid epidemic, Anthem pledged four years ago to ensure significantly more members received both drug therapy and counseling treatment in an effort to treat both mind and body.

Anthem met these goals by boosting the combined percentage of consumers in employer-based, individual and Medicaid plans with opioid use disorder receiving both therapies from 22% to 56%. Medicaid plans alone increased from 24% to 65%.

Learn more.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Joshua Kaufman, MD, CDPHP
Cathy Eng, MD, FACP, FASCO
Andrew Kuykendall, MD, Moffitt Cancer Center
Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Douglas Flora, MD, FACCC
rachel rohaidy
Douglas Flora, MD, FACCC
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.